| Literature DB >> 35269848 |
Chupalav Eldarov1, Alina Gamisonia1, Vitaliy Chagovets1, Luiza Ibragimova1, Svetlana Yarigina1, Veronika Smolnikova1, Elena Kalinina1, Nataliya Makarova1, Victor Zgoda2, Gennady Sukhikh1,3, Mikhail Bobrov1.
Abstract
In this study we evaluated possible differences in metabolomic profiles of spent embryo culture media (SECM) of human embryos with distinct morphology, karyotype, and implantation outcomes. A total of 153 samples from embryos of patients undergoing in vitro fertilization (IVF) programs were collected and analyzed by HPLC-MS. Metabolomic profiling and statistical analysis revealed clear clustering of day five SECM from embryos with different morphological classes and karyotype. Profiling of day five SECM from embryos with different implantation outcomes showed 241 significantly changed molecular ions in SECM of successfully implanted embryos. Separate analysis of paired SECM samples on days three and five revealed 46 and 29 molecular signatures respectively, significantly differing in culture media of embryos with a successful outcome. Pathway enrichment analysis suggests certain amino acids, vitamins, and lipid metabolic pathways to be crucial for embryo implantation. Differences between embryos with distinct implantation potential are detectable on the third and fifth day of cultivation that may allow the application of culture medium analysis in different transfer protocols for both fresh and cryopreserved embryos. A combination of traditional morphological criteria with metabolic profiling of SECM may increase implantation rates in assisted reproductive technology programs as well as improve our knowledge of the human embryo metabolism in the early stages of development.Entities:
Keywords: LC-MS; aneuploidy; exometabolomics; human embryo; implantation; metabolomics
Mesh:
Substances:
Year: 2022 PMID: 35269848 PMCID: PMC8911215 DOI: 10.3390/ijms23052706
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Distribution of 5-day embryos into arbitrary classes. Alphanumerical morphological grades for blastocysts in Classes 1–3 were evaluated based on Gardner classification. The numbers of samples in each group and the distribution of euploid/aneuploid embryos are shown as well.
| Groups | Class 1 | Class 2 | Class 3 | Class 4 | ||
|---|---|---|---|---|---|---|
| “Excellent” | “Good” | “Fair” | “Poor” | |||
| Grades | 6AA, 6BA, 4AA, 4AB, 3AA | 4BA, 4BB, 3AB, 3BB, 3BA | 3BC, 3CB, 3CC | 10b-5b, 10c-3c, 2pb, 2pn, atresia | ||
| Karyotype | Euploid | Aneuploid | Euploid | Aneuploid | N/D | N/D |
| Number | 23 | 12 | 22 | 21 | 20 | 55 |
Figure 1Score plot of intergroup PLS-DA of day 5 culture medium samples from embryos of different morphological classes.
Figure 2Score plot of intragroup comparison of metabolite profiles of day 5 culture medium samples from the class 1 embryos by PLS-DA. Samples are grouped according to morphological classification for day 5 embryos.
Figure 3Score plot of OPLS-DA comparative analysis of metabolomic profiles of day 5 culture media samples from the 1st class embryos with euploid and aneuploid karyotypes.
Molecular ions which distinguish day 5 culture media of aneuploid and euploid embryos. RT—retention time; FC—Fold Change (significantly different between groups with p < 0.05 based on univariate statistics). Italics indicate molecular ions identified by HMDB: m/z 309.204—16-hydroxy-10-oxohexadecanoic acid; m/z 389.252—5,6-dihydroxyprostaglandin F1.
| Retention Time | Fold Change | Retention Time | Fold Change | ||
|---|---|---|---|---|---|
| 314.780 | 0.94 | 2.42 | 354.896 | 1.02 | 3.28 |
| 450.755 | 0.96 | 2.29 | 330.934 | 1.05 | 2.31 |
| 448.789 | 0.97 | 2.03 |
| 1.34 | 2.76 |
| 436.871 | 0.97 | 2.64 | 370.281 | 11.98 | 3.11 |
| 333.844 | 0.97 | 2.97 | 248.106 | 13.6 | 2.31 |
| 411.860 | 0.97 | 4.72 | 354.286 | 14.58 | 2.03 |
| 234.171 | 0.98 | 3.25 | 412.328 | 16.64 | 2.06 |
| 530.769 | 0.99 | 2.64 |
| 16.65 | 3.11 |
| 316.87 | 0.99 | 2.04 | 384.296 | 16.66 | −2.00 |
| 410.857 | 0.99 | 2.52 | 368.273 | 16.67 | 2.79 |
| 402.825 | 1.00 | 2.66 | 169.978 | 29.8 | 2.02 |
Pathway enrichment of molecular ion identifications contributing to the difference in day 5 SECM of aneuploid and euploid embryos. Molecular ions filtered by PLS-DA were mapped to HMDB database, list of identified metabolites was then mapped to KEGG pathways database. ‘p’ refers to the raw p-value determined by Fisher’s exact test; ‘Impact’ refers to topological impact on pathway (routing betweenness centrality score).
| Pathway Name | Matched |
| Impact |
|---|---|---|---|
| Pentose phosphate pathway | 5/22 | 0.51 | 0.48 |
| Valine, leucine, and isoleucine biosynthesis | 2/8 | 0.53 | 0 |
| Vitamin B6 metabolism | 2/9 | 0.6 | 0.57 |
| Phenylalanine metabolism | 2/10 | 0.66 | 0.14 |
| alpha-Linolenic acid metabolism | 2/13 | 0.8 | 0 |
| Butanoate metabolism | 2/15 | 0.86 | 0.03 |
| Histidine metabolism | 2/16 | 0.88 | 0.28 |
| Retinol metabolism | 2/17 | 0.9 | 0.22 |
| Caffeine metabolism | 1/10 | 0.91 | 0 |
| Biotin metabolism | 1/10 | 0.91 | 0.2 |
| Terpenoid backbone biosynthesis | 2/18 | 0.92 | 0.01 |
| Pentose and glucuronate interconversions | 2/18 | 0.92 | 0.08 |
| Arginine and proline metabolism | 5/38 | 0.93 | 0.26 |
| Pantothenate and CoA biosynthesis | 2/19 | 0.93 | 0.01 |
| Glycine, serine, and threonine metabolism | 4/33 | 0.94 | 0.15 |
| Valine, leucine, and isoleucine degradation | 5/40 | 0.95 | 0.03 |
| Alanine, aspartate, and glutamate metabolism | 3/28 | 0.95 | 0.09 |
Figure 4Score plot of OPLS-DA comparative multivariate statistical analysis of metabolomic profiles of day 5 culture media samples from embryos of the first morphological class with successful and unsuccessful implantation.
Selected molecular ions identified in SECM from implanted embryos after 5 days of continuous cultivation. Identifications were performed by mapping molecular ions m/z to HMDB metabolites database (accuracy ≤ 15 ppm). Fold change indicates relative change of mean integrated area of chromatographic peak for this ion when compared with SECM from embryos with unsuccessful implantation.
| Retention Time | Name | Fold Change | |
|---|---|---|---|
| 110.058 | 1.04 | 4-Aminobutyraldehyde | −3.03 |
| 114.066 | 1.12 | Creatinine | −2.42 |
| 116.071 | 1.06 | L-Proline | −2.27 |
| 118.086 | 1.06 | L-Valine | −5.8 |
| 119.082 | 1.35 | L-2,4-diaminobutyric acid | −2.09 |
| 130.087 | 1.00 | Pipecolic acid | −2.9 |
| 132.077 | 1.55 | Creatine | −2.91 |
| 147.066 | 8.1 | Adipic acid | −7.47 |
| 153.055 | 1.03 | p-Hydroxyphenylacetic acid | −2.14 |
| 163.072 | 1.00 | L-4-Hydroxyglutamine | −5.04 |
| 166.087 | 2.58 | L-Phenylalanine | −88.24 |
| 219.111 | 7.83 | N-Acetylserotonin | −15.24 |
| 227.08 | 7.62 | L-Tryptophan | −2.7 |
| 264.106 | 9.68 | L-erythro-tetrahydrobiopterin | −3.32 |
| 269.09 | 13.67 | Inosine | −2.01 |
| 280.093 | 1.05 | Glycerophosphocholine | −2.28 |
| 309.204 | 1.33 | Hexadecanedioic acid | −2.61 |
| 469.051 | 1.04 | CDP-ethanolamine | −2.36 |
Figure 5Mass spectra of MSn analysis for L-Phenylalanine and L-tryptophan.
Pathway enrichment of molecular ions identifications contributing to the difference in SECM from embryos with successful and unsuccessful implantation in continuous protocol. Molecular ions filtered by PLS-DA were mapped to HMDB database, list of identified metabolites was then mapped to KEGG pathways database. ‘p’ refers to the raw p-value determined by Fisher’s exact test; ‘Impact’ refers to topological impact on pathway (routing betweenness centrality score).
| Pathway Name | Matched |
| Impact |
|---|---|---|---|
| Vitamins | |||
| Vitamin B6 metabolism | 2/9 | 0.48 | 0.13 |
| Lipids | |||
| Linoleic acid metabolism | 3/5 | 0.04 | 0 |
| Steroid biosynthesis | 5/42 | 0.88 | 0.09 |
| Amino acids | |||
| Valine, leucine and isoleucine biosynthesis | 2/8 | 0.42 | 0 |
| Valine, leucine and isoleucine degradation | 4/40 | 0.94 | 0.04 |
| Phenylalanine metabolism | 2/10 | 0.54 | 0.36 |
| Histidine metabolism | 2/16 | 0.8 | 0.22 |
| Arginine and proline metabolism | 5/38 | 0.82 | 0.1 |
| Cysteine and methionine metabolism | 4/33 | 0.86 | 0.14 |
| Tyrosine metabolism | 5/42 | 0.88 | 0.12 |
| Aminoacyl-tRNA biosynthesis | 5/48 | 0.94 | 0 |
| Other | |||
| Butanoate metabolism | 2/15 | 0.77 | 0.14 |
| Propanoate metabolism | 2/23 | 0.93 | 0.04 |
| Caffeine metabolism | 3/10 | 0.25 | 0.69 |
| Pentose and glucuronate interconversions | 4/18 | 0.39 | 0.2 |
| Nicotinate and nicotinamide metabolism | 1/15 | 0.94 | 0 |
Figure 6Score plot of OPLS-DA of metabolomic profiles of day 3 (A) and day 5 (B) culture media samples from euploid embryos of 1st morphological class with successful and unsuccessful implantation.
Pathway enrichment of molecular ions identifications contributing to the difference in 3rd day SECM from embryos with successful and unsuccessful implantation in discontinuous protocol. Molecular ions filtered by PLS-DA were mapped to HMDB database, list of identified metabolites was then mapped to KEGG pathways database. ‘p’ refers to the raw p-value determined by Fisher’s exact test; ‘Impact’ refers to topological impact on pathway (routing betweenness centrality score).
| Pathway Name | Matched |
| Impact |
|---|---|---|---|
| Vitamins | |||
| Vitamin B6 metabolism | 2/9 | 0.43 | 0.54 |
| Retinol metabolism | 5/17 | 0.11 | 0.22 |
| Lipids | |||
| alpha-Linolenic acid metabolism | 3/13 | 0.34 | 0.33 |
| Glycerophospholipid metabolism | 3/36 | 0.94 | 0.12 |
| Biosynthesis of unsaturated fatty acids | 4/36 | 0.84 | 0.00 |
| Terpenoid backbone biosynthesis | 1/18 | 0.96 | 0.00 |
| Sphingolipid metabolism | 1/21 | 0.97 | 0.00 |
| Amino Acids | |||
| Histidine metabolism | 1/16 | 0.94 | 0.19 |
| Arginine biosynthesis | 1/14 | 0.91 | 0.08 |
| Arginine and proline metabolism | 3/38 | 0.95 | 0.14 |
| Cysteine and methionine metabolism | 2/33 | 0.98 | 0.06 |
| Valine, leucine, and isoleucine degradation | 3/40 | 0.96 | 0.01 |
| Valine, leucine, and isoleucine biosynthesis | 3/8 | 0.12 | 0.00 |
| Sugars | |||
| Pentose and glucuronate interconversions | 1/18 | 0.96 | 0.14 |
| Starch and sucrose metabolism | 1/18 | 0.96 | 0.00 |
| Other | |||
| Caffeine metabolism | 2/10 | 0.48 | 0.00 |
Pathway enrichment of molecular ions identifications contributing to the difference in 5th day SECM from embryos with successful and unsuccessful implantation in discontinuous protocol. Molecular ions filtered by PLS-DA were mapped to HMDB database, list of identified metabolites was then mapped to KEGG pathways database. ‘p’ refers to the raw p-value determined by Fisher’s exact test; ‘Impact’ refers to topological impact on pathway (routing betweenness centrality score).
| Pathway Name | Matched |
| Impact |
|---|---|---|---|
| Vitamins | |||
| Vitamin B6 metabolism | 2/9 | 0.63 | 0.54 |
| Retinol metabolism | 3/17 | 0.77 | 0.37 |
| Amino acids | |||
| Phenylalanine metabolism | 4/10 | 0.17 | 0.74 |
| Phenylalanine, tyrosine, and tryptophan biosynthesis | 2/4 | 0.22 | 1.00 |
| Valine, leucine, and isoleucine, biosynthesis | 3/8 | 0.26 | 0.00 |
| Arginine biosynthesis | 2/14 | 0.86 | 0.08 |
| Arginine and proline metabolism | 6/38 | 0.89 | 0.11 |
| Lipids | |||
| Arachidonic acid metabolism | 10/36 | 0.28 | 0.26 |
| Terpenoid backbone biosynthesis | 3/18 | 0.81 | 0.19 |
| Sugars | |||
| Galactose metabolism | 5/27 | 0.76 | 0.12 |
| Other | |||
| Ubiquinone and other terpenoid-quinone biosynthesis | 2/9 | 0.63 | 0.00 |
| Caffeine metabolism | 5/10 | 0.05 | 1.00 |